Attached files
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Amendment No. 2 to the Registration Statement on Form S-1 of our report dated August 3, 2010, relating to the consolidated financial statements of Horizon Pharma, Inc., (formerly Horizon Therapeutics, Inc.), which appears in such Registration Statement. We also consent to the reference to us under the heading Experts in such Registration Statement.
/s/ PRICEWATERHOUSECOOPERS LLP
PricewaterhouseCoopers LLP
San Jose, California
October 8, 2010